Clinical Trials Logo

Invasive Candidiasis clinical trials

View clinical trials related to Invasive Candidiasis.

Filter by:

NCT ID: NCT00520234 Completed - Clinical trials for Invasive Candidiasis

Randomized Study of Caspofungin Prophylaxis Followed by Pre-emptive Therapy for Invasive Candidiasis in the Intensive Care Unit (ICU)

MSG-01
Start date: August 2007
Phase: Phase 4
Study type: Interventional

Adults admitted to intensive care units are at risk for a variety of complications. Infections due to the fungus called candida are of particular concern. The study will test the possibility that caspofungin, a new therapy for fungal infections, can successfully reduce the rate of candida infections in subjects at risk. It will also test if caspofungin is useful in treating subjects for this disease when diagnosed using a new blood test that is performed twice weekly, permitting earlier diagnosis than current practice standards.

NCT ID: NCT00250432 Completed - Clinical trials for Invasive Candidiasis

A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults (0991-801)(COMPLETED)

Start date: January 2006
Phase: Phase 3
Study type: Interventional

Comparison of the safety and effectiveness of standard drug dosing versus a daily dose 3 times higher than the standard dose in patients with invasive candidiasis (bloodstream and/or systemic yeast infections)

NCT ID: NCT00189709 Completed - Candidemia Clinical Trials

Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia

Start date: August 2004
Phase: Phase 3
Study type: Interventional

To determine the efficacy and safety of micafungin (FK463) versus fluconazole (Diflucan) in treating patients with invasive candidiasis or candidaemia